Practical implications of current natriuretic peptide research.

Area of Science:

• Endocrinology and Cardiovascular Physiology
• Biomarker Discovery and Therapeutic Development

Background:

• Review of natriuretic peptide research, focusing on atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP).
• Exploration of the physiological and pathophysiological significance of natriuretic peptides in cardiovascular disease.

Discussion:

• Measurement of plasma ANP and BNP levels has limited diagnostic value but strong negative predictive value for cardiac impairment.
• Elevated BNP levels post-myocardial infarction indicate a poor prognosis, aiding in patient selection for further investigation.
• Potential role of natriuretic peptides in guiding heart failure therapy and managing conditions with volume overload.

Key Insights:

• Normal plasma natriuretic peptide levels suggest a low risk of cardiac impairment.
• Consistently elevated BNP levels after myocardial infarction are linked to significantly worse outcomes.
• Natriuretic peptides offer therapeutic potential for hypertension and volume overload states.

Outlook:

• Development of orally active agents, such as vasopeptidase inhibitors, to enhance endogenous natriuretic peptide activity.
• Potential for dual inhibitors to offer broad-spectrum benefits beyond current treatments for hypertension and heart failure.